AstraZeneca, the UK-based maker of popular inhalers like Symbicort and Airsupra, announced Monday it plans to cap costs for patients using its inhalers in the U.S. at $35 per month starting June 1. The inhalers treat asthma and chronic obstructive pulmonary disease, which combined affect roughly 41 million Americans…
Widely Used Inhalers Won't Cost More Than $35 a Month, AstraZeneca Says
1 month ago
36
- Homepage
- Technology
- Widely Used Inhalers Won't Cost More Than $35 a Month, AstraZeneca Says
Related
Trending
Popular
Inside the Golden Globes 2024 afterparties: See how celebrit...
3 months ago
1172
So You Wanna Talk About the Best CBD Brands? Our 7 Picks and...
9 months ago
837
What do tickets cost to see the ‘How Did This Get Made’ podc...
8 months ago
710
Sennheiser Momentum True Wireless 4 Review: Decent Sound but...
2 months ago
710
Travel Behind the Scenes of Star Wars Outlaws
9 months ago
492
© Portal.News 2024. All rights are reserved